Literature DB >> 30481275

Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition.

Laura Costas1, Leila Lujan-Barroso2,3, Yolanda Benavente1,4, Naomi E Allen5, Pilar Amiano4,6, Eva Ardanaz4,7, Caroline Besson8,9,10, Heiner Boeing11, Bas Bueno-de-Mesquita12,13,14,15, Iris Cervenka9,10, Renée T Fortner16, Agnès Fournier9,10, Marc Gunter17, Sophia Harlid18, José María Huerta4,19, Mats Jerkeman20, Karin Jirström20, Rudolf Kaaks16, Anna Karakatsani21,22, Kay-Tee Khaw23, Anastasia Kotanidou21,24, Eiliv Lund25, Giovanna Masala26, Amalia Mattiello27, Beatrice Melin18, Virginia Menéndez28, Neil Murphy17, Alexandra Nieters29, Kim Overvad30, Elio Riboli31, Carlotta Sacerdote32, Maria-Jose Sánchez4,33, Julie A Schmidt34, Sabina Sieri35, Anne Tjønneland36, Antonia Trichopoulou21, Rosario Tumino37, Roel Vermeulen38, Elisabete Weiderpass25,39,40,41,42, Silvia de Sanjosé43, Antonio Agudo2, Delphine Casabonne1,4.   

Abstract

The role of hormonal factors in the etiology of lymphoid neoplasms remains unclear. Previous studies have yielded conflicting results, have lacked sufficient statistical power to assess many lymphoma subtypes, or have lacked detailed information on relevant exposures. Within the European Prospective Investigation Into Cancer and Nutrition cohort, we analyzed comprehensive data on reproductive factors and exogenous hormone use collected at baseline (1992-2000) among 343,458 women, including data on 1,427 incident cases of B-cell non-Hodgkin lymphoma (NHL) and its major subtypes identified after a mean follow-up period of 14 years (through 2015). We estimated hazard ratios and 95% confidence intervals using multivariable proportional hazards modeling. Overall, we observed no statistically significant associations between parity, age at first birth, breastfeeding, oral contraceptive use, or ever use of postmenopausal hormone therapy and risk of B-cell NHL or its subtypes. Women who had undergone surgical menopause had a 51% higher risk of B-cell NHL (based on 67 cases) than women with natural menopause (hazard ratio = 1.51, 95% confidence interval: 1.17, 1.94). Given that this result may have been due to chance, our results provide little support for the hypothesis that sex hormones play a role in lymphomagenesis.

Entities:  

Mesh:

Year:  2019        PMID: 30481275      PMCID: PMC6357796          DOI: 10.1093/aje/kwy259

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  47 in total

1.  Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women.

Authors:  R A Nelson; A M Levine; L Bernstein
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

Review 2.  The emerging role of estrogen in B cell malignancies.

Authors:  Eleni-Eirini Ladikou; Eva Kassi
Journal:  Leuk Lymphoma       Date:  2016-08-25

3.  Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies.

Authors:  E V Kane; E Roman; N Becker; L Bernstein; P Boffetta; P M Bracci; J R Cerhan; B C-H Chiu; P Cocco; L Costas; L Foretova; E A Holly; C La Vecchia; K Matsuo; M Maynadie; S Sanjose; J J Spinelli; A Staines; R Talamini; S S Wang; Y Zhang; T Zheng; A Kricker
Journal:  Ann Oncol       Date:  2012-07-10       Impact factor: 32.976

4.  Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.

Authors:  Yani Lu; Sophia S Wang; Jane Sullivan-Halley; Ellen T Chang; Christina A Clarke; Katherine D Henderson; Huiyan Ma; Lei Duan; James V Lacey; Dennis Deapen; Leslie Bernstein
Journal:  Int J Cancer       Date:  2010-12-08       Impact factor: 7.396

5.  Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women.

Authors:  Yawei Zhang; Theodore R Holford; Brian Leaderer; Shelia Hoar Zahm; Peter Boyle; Lindsay McOmber Morton; Bing Zhang; Kaiyong Zou; Stuart Flynn; Giovanni Tallini; Patricia H Owens; Tongzhang Zheng
Journal:  Cancer Causes Control       Date:  2004-05       Impact factor: 2.506

6.  Self-reported data on reproductive variables were reliable among postmenopausal women.

Authors:  Raquel Lucas; Ana Azevedo; Henrique Barros
Journal:  J Clin Epidemiol       Date:  2008-05-12       Impact factor: 6.437

7.  Long-term impact of reproductive factors on cancer risk.

Authors:  C La Vecchia; E Negri; S Franceschi; F Parazzini
Journal:  Int J Cancer       Date:  1993-01-21       Impact factor: 7.396

8.  Reproductive factors and non-Hodgkin lymphoma risk in the California Teachers Study.

Authors:  Jennifer Prescott; Yani Lu; Ellen T Chang; Jane Sullivan-Halley; Katherine D Henderson; Christina A Clarke; Huiyan Ma; Claire Templeman; Dennis Deapen; Leslie Bernstein
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

9.  Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.

Authors:  K Yakimchuk; M Iravani; M S Hasni; P Rhönnstad; S Nilsson; M Jondal; S Okret
Journal:  Leukemia       Date:  2011-04-19       Impact factor: 11.528

10.  Inhibition of estrogen biosynthesis enhances lymphoma growth in mice.

Authors:  Gergely Talaber; Konstantin Yakimchuk; Jiyu Guan; Jose Inzunza; Sam Okret
Journal:  Oncotarget       Date:  2016-04-12
View more
  2 in total

1.  Increased Risk of Lymphoma in Men or the Elderly Infected with Tuberculosis.

Authors:  Guo Li; Guang-Liang Chen; Yong Zhou; Gui-Qin Yao; Shun'e Yang; Dong-Mei Ji
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-09-01       Impact factor: 2.576

2.  Association between Cholesterol Level and the Risk of Hematologic Malignancy According to Menopausal Status: A Korean Nationwide Cohort Study.

Authors:  Wonyoung Jung; Keun Hye Jeon; Jihun Kang; Taewoong Choi; Kyungdo Han; Sang-Man Jin; Su-Min Jeong; Dong Wook Shin
Journal:  Biomedicines       Date:  2022-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.